|
Volumn 23, Issue 4, 1996, Pages 685-693
|
Drug interactions in patients infected with human immunodeficiency virus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
ASTEMIZOLE;
CLARITHROMYCIN;
COTRIMOXAZOLE;
CYTOCHROME P450;
DIDANOSINE;
ETHAMBUTOL;
FLUCONAZOLE;
GANCICLOVIR;
INDINAVIR;
ISONIAZID;
ITRACONAZOLE;
KETOCONAZOLE;
LAMIVUDINE;
MACROLIDE;
PENTAMIDINE;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
SULFADIAZINE;
TERFENADINE;
THEOPHYLLINE;
UNINDEXED DRUG;
VINCRISTINE;
ZALCITABINE;
ZIDOVUDINE;
AIDS RELATED COMPLEX;
BONE MARROW SUPPRESSION;
DRUG ANTAGONISM;
DRUG MECHANISM;
DRUG MIXTURE;
DRUG POTENTIATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KIDNEY FUNCTION;
MYCOBACTERIOSIS;
NOTE;
OPPORTUNISTIC INFECTION;
ORAL DRUG ADMINISTRATION;
PANCREATITIS;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
|
EID: 0029742853
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1093/clinids/23.4.685 Document Type: Note |
Times cited : (144)
|
References (8)
|